Authors
Latest:
OPINION: Will Class-Wide REMS Programs Delay New Opioid Approvals?Class-wide opioid REMS will affect four million patients and require cooperation of more than 25 drug manufacturers
Latest:
Not just 'social listening' but social understandingHow new social health analytics tools are supercharging pharma's quest for patient insight
Latest:
Getting Value From End-of-Life-Cycle PharmaceuticalsA review of 84 branded pharmaceutical products with changed ownership as of 2005 shows that many of them can continue to sell, often with much higher prices By Albert I. Wertheimer, PhD, MBA, Temple University, and Ellen F. Loh, BS, MBA, University of Maryland, Baltimore
Latest:
Organizing Your Commercial Compliance ProgramsRegulatory attention has intensified over commercial activities. Here’s what to do to minimize risks and raise compliance levels
Latest:
Monetizing Intellectual Property: Royalties, Revenues and Alternative Sources of CapitalInvestment funds have developed an interest in trading capital for royalties on drug commercializations
Latest:
Supply chains for a patient-centric worldTomorrow's healthcare market, driven by consumer choice and outcomes-driven economics, will create new supply chain models
Latest:
Worldwide, pharma distribution is moving to a serial-coded basisRegardless of how pending US legislation is resolved, manufacturers need to move ahead
Latest:
How to Ensure Successful Design and Implementation of Physician SegmentationThe basic process of defining customer segments and appropriate promotional messaging benefits from a cross-disciplinary approach
Latest:
Outsourced facilities management saves precious financial resourcesLife sciences companies - including mid-market ones - are finding value in an outsourced service
Latest:
A new way to look at the performance of passive cold-chain shipping containersA 'performance curve' chart for containers could simplify the design process
Latest:
Liberating time in the Economy of AttentionPharmaceutical marketing is now operating in a new landscape--the Economy of Attention
Latest:
Supreme Court: reverse payment settlements subject to antitrust scrutinyWhat are the risks of future 'pay for delay' settlements between branded and generic manufacturers?
Latest:
Change is a constant for sales incentive planningSales Compensation Solutions, a new book from ZS Associates, outlines problems and solutions
Latest:
Landmarks to sampling in a digitized healthcare environmentThe accelerating adoption of electronic health records, e-prescribing and mobile technologies will change the conventions of sample distribution
Latest:
A scientific approach to site selectionApplying a consistent framework to choose locations can help optimize R&D and drive cost reduction for pharmaceutical companies of all sizes
Latest:
Defending Fair Market Value (FMV) AssessmentsTo avoid anti-kickback litigation with government, pharma companies need a defensible position on FMV assessments
Latest:
Powering up medical affairsTechnology is enabling more resources to reach the medical affairs teams—in a compliant manner
Latest:
Medical-Claims Database Analysis of Off-Label PrescribingExamining off-label use of highly prescribed drugs reveals factors that differ from the usual criticism of such usage
Latest:
Bringing room-temperature pharma shipping under the 'CRT' umbrella'Controlled room temperature' (CRT) shipping is being transformed from standard shipping processes to engineered, compliance-ready processes and materials
Latest:
Protecting pharmaceutical exclusivity: Avoiding the hidden dangers of double patentingMultiple patents contribute to a robust portfolio; however, each patent that issues can potentially become a landmine to another
Latest:
Evidence Generation Is the Foundation to Optimal Product PositioningEvidence Generation Is the Foundation to Optimal Product Positioning
Latest:
How to Ensure Successful Design and Implementation of Physician SegmentationThe basic process of defining customer segments and appropriate promotional messaging benefits from a cross-disciplinary approach
Latest:
Thermoformable packaging’s role in an evolving pharmaceutical industryPackaging materials have an impact in regulatory compliance, patient safety and drug efficacy
Latest:
Network effect of industry-crowdsourced physician dataDiving for customer insights through an ocean of crowdsourced data
Latest:
The Logistics of a Successful Product LaunchA collaborative working relationship gives launch day a better chance at success
Latest:
Educating patients on self-administered drug injectionsThe trend toward self-administered drugs creates a pressing need for better patient-education resources
